Janssen (Belgium)

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Janssen Research & Development (United States)美国3
2. KU Leuven比利时3
3. Janssen (United Kingdom)英国2
4. Janssen (Netherlands)荷兰2
5. Cilag (Switzerland)2
6. University of Messina意大利1
7. UCB Pharma (Belgium)比利时1
8. AbbVie (United States)美国1

按月发文

逐年被引

最新文献

1. 1
   Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United StatesBMC Public Health202440
2. 2
   Linking material properties to 1D-PBM parameters towards a generic model for twin-screw wet granulationProcess Safety and Environmental Protection202311
3. 3
   Iterative model-based optimal experimental design for mixture-process variable models to predict solubilityProcess Safety and Environmental Protection20225
4. 4
   Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databasesPharmacoepidemiology and Drug Safety20224
5. 5
   Development and performance characteristics of novel code‐based algorithms to identify invasive Escherichia coli diseasePharmacoepidemiology and Drug Safety20223
6. 6
   The DIANA Study: Continued Access to Darunavir/Ritonavir (DRV/r) and Long-Term Safety Follow-Up in HIV-1-Infected Pediatric Patients Aged 3 to < 18 YearsDrug Safety20201
7. 7
   Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic SteatohepatitisDrug Safety202041
8. 8
   Process safety education: Selecting the concepts for a process safety program (article 1/2)Process Safety Progress20208
9. 9
   Characterization method for mass mixing in batch reactors based on temperature profilesProcess Safety and Environmental Protection20205
10. 10
    Methods for time‐varying exposure related problems in pharmacoepidemiology: An overviewPharmacoepidemiology and Drug Safety2017145

高被引文献

1. 1
   Methods for time‐varying exposure related problems in pharmacoepidemiology: An overviewPharmacoepidemiology and Drug Safety2017145
2. 2
   Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic SteatohepatitisDrug Safety202041
3. 3
   Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United StatesBMC Public Health202440
4. 4
   Linking material properties to 1D-PBM parameters towards a generic model for twin-screw wet granulationProcess Safety and Environmental Protection202311
5. 5
   Combining evidence from multiple electronic health care databases: performances of one‐stage and two‐stage meta‐analysis in matched case‐control studiesPharmacoepidemiology and Drug Safety20178
6. 6
   Process safety education: Selecting the concepts for a process safety program (article 1/2)Process Safety Progress20208
7. 7
   Characterization method for mass mixing in batch reactors based on temperature profilesProcess Safety and Environmental Protection20205
8. 8
   Iterative model-based optimal experimental design for mixture-process variable models to predict solubilityProcess Safety and Environmental Protection20225
9. 9
   Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databasesPharmacoepidemiology and Drug Safety20224
10. 10
    Development and performance characteristics of novel code‐based algorithms to identify invasive Escherichia coli diseasePharmacoepidemiology and Drug Safety20223

主要发表期刊